Cardiovascular Research

Article	Citations
Global burden of heart failure: a comprehensive and updated review of epidemiology	574
Cardiac fibrosis	425
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science	314
Regional and global contributions of air pollution to risk of death from COVID-19	210
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities	195
Vascular smooth muscle cells in atherosclerosis: time for a re-assessment	181
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes	173
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation	165
Angiogenesis after acute myocardial infarction	151
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction	108
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome	106
Neutrophil extracellular traps: from physiology to pathology	105
Metabolic inflammation in heart failure with preserved ejection fraction	101
Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta	98
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute Card	93
Senescence mechanisms and targets in the heart	91
Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab	89
Environmental risk factors and cardiovascular diseases: a comprehensive expert review	87
NLRP3 inflammasome as a key driver of vascular disease	84
Obesity, kidney dysfunction, and inflammation: interactions in hypertension	82
Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart	78
The role of CD36 in cardiovascular disease	75
Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function	75
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart	71
mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification	70

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes	68
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias	68
Pathophysiology of atrial fibrillation and chronic kidney disease	64
COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction	63
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working	60
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function	58
Inflammation and cardiovascular diseases: lessons from seminal clinical trials	58
The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis	57
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications	57
Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets	57
Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm	56
Emerging views of statin pleiotropy and cholesterol lowering	56
Mechanism of succinate efflux upon reperfusion of the ischaemic heart	56
Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases	56
Ketones can become the major fuel source for the heart but do not increase cardiac efficiency	53
Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group	51
Physiological and pathological roles of protein kinase A in the heart	51
Risk factors profile of young and older patients with myocardial infarction	50
Inflammation during the life cycle of the atherosclerotic plaque	50
Association of cardiometabolic microRNAs with COVID-19 severity and mortality	50
Loss of SIRT1 in diabetes accelerates DNA damage-induced vascular calcification	50
Transthyretin cardiac amyloidosis	49
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis	48
Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care	48
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles	47
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Funct	47
Heart failure with preserved ejection fraction: insights into diagnosis and pathophysiology	46
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications	46
Dietary recommendations for prevention of atherosclerosis	46
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts	45
Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension	45
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart	44
Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography	44
PCSK9 and LRP5 in macrophage lipid internalization and inflammation	43
High spatial endothelial shear stress gradient independently predicts site of acute coronary plaque rupture and erosion	43
Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy	42
How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management	42
From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?	42
Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis	41
Relationship between lipoproteins, thrombosis, and atrial fibrillation	41
Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart	41
Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation	41
The long and winding road of cardiomyocyte maturation	40
Soil and water pollution and human health: what should cardiologists worry about?	40
Regenerative potential of epicardium-derived extracellular vesicles mediated by conserved miRNA transfer	40
Myocardin-related transcription factor A regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice	39
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim	39
Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling	39
Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart	39
Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions	38

Titin (TTN): from molecule to modifications, mechanics, and medical significance	38
Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation	38
The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease	37
Quantifying technical confounders in microbiome studies	37
Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank	37
Efficacy and limitations of senolysis in atherosclerosis	37
The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease	37
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working	35
Neuroscientific therapies for atrial fibrillation	35
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis	34
Sex differences in cardiorespiratory fitness are explained by blood volume and oxygen carrying capacity	34
The role of autophagy in cardiovascular pathology	34
Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function	33
Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis	33
Exercise effects on cardiovascular disease: from basic aspects to clinical evidence	33
VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes	33
Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq	33
Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity	33
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications	33
Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure	33
TNAP as a therapeutic target for cardiovascular calcification: a discussion of its pleiotropic functions in the body	32
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission	32
Ventricular fibrillation mechanism and global fibrillatory organization are determined by gap junction coupling and fibrosis pattern	32
Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis	32
From organic and inorganic phosphates to valvular and vascular calcifications	32
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it	31
Single-cell RNA sequencing reveals cell type- and artery type-specific vascular remodelling in male spontaneously hypertensive rats	31
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study	31
Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure	31
Metabolic alterations in a rat model of takotsubo syndrome	31
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics	31
Coronary microcirculation damage in anthracycline cardiotoxicity	30
Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase	30
Single-cell transcriptomic analyses of cardiac immune cells reveal that Rel-driven CD72-positive macrophages induce cardiomyocyte injury	30
Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes	30
Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials	30
Single-cell dual-omics reveals the transcriptomic and epigenomic diversity of cardiac non-myocytes	30
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions	30
Vascular histopathology and connective tissue ultrastructure in spontaneous coronary artery dissection: pathophysiological and clinical implications	29
EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization	29
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis	29
Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis	29
Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction	29
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension	29
Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals	29
Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production	28
Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?	28
Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study	28
Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function	28
Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment	28
Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression	27
Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1–CX3CL1 interaction	27
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes	27
MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling	27
Impaired retinal microvascular function predicts long-term adverse events in patients with cardiovascular disease	27
NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli	26
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up	26
Caloric restriction mimetics for the treatment of cardiovascular diseases	26
G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure	26
Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro	26
Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10	26
A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease	26
Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness	26
The vasculature: a therapeutic target in heart failure?	25
A combined microRNA and target protein-based panel for predicting the probability and severity of uraemic vascular calcification: a translational study	25
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart	25
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches	25
Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?	25
Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression	25
Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycaemia: reduced repolarization reserve, neurohormonal stimulation, and heart failure exacerbate susceptibility	25
The impact of aircraft noise on vascular and cardiac function in relation to noise event number: a randomized trial	25
Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension	25
Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension	24
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy	24
Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact	24
Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death	24
The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells	24
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy	24
Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts	24
Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction	24

New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation	24
Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension	24
Cardio-metabolic consequences of dietary carbohydrates: reconciling contradictions using nutritional geometry	24
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance	24
Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction	24
Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells	24
The complex network of mTOR signalling in the heart	23
Ketone therapy for heart failure: current evidence for clinical use	23
Network medicine in Cardiovascular Research	23
Innate and adaptive immunity: the understudied driving force of heart valve disease	23
Impairment of mitophagy and autophagy accompanies calcific aortic valve stenosis favouring cell death and the severity of disease	23
Management of cardiac fibrosis is the largest unmet medical need in heart failure	23
Cardiac cellularity is dependent upon biological sex and is regulated by gonadal hormones	23
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology	23
Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry	23
Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies	23
Sequence meets function—microbiota and cardiovascular disease	23
Chitinase 3 like 1 is a regulator of smooth muscle cell physiology and atherosclerotic lesion stability	23
Molecular mechanisms and clinical implications of multiple forms of mitophagy in the heart	23
Asymmetric Hapln1a drives regionalized cardiac ECM expansion and promotes heart morphogenesis in zebrafish development	23
The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism	23
Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling	22
Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart	22
Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcircul	22
Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes	22
Natriuretic peptide pathways in heart failure: further therapeutic possibilities	22
Chronically elevated branched chain amino acid levels are pro-arrhythmic	22
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions	22
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice	22
Cardiac metabolism in HFpEF: from fuel to signalling	22
Autonomic innervation of the carotid body as a determinant of its sensitivity: implications for cardiovascular physiology and pathology	22
The voltage-gated potassium channel KV1.3 regulates neutrophil recruitment during inflammation	21
Two-faced Janus: the dual role of macrophages in atherosclerotic calcification	21
Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocar	21
HDAC1: an environmental sensor regulating endothelial function	21
Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart	21
Sex differences in acute cardiovascular care: a review and needs assessment	21
Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease	21
MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease	21
Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health	20
The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure	20
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signalling pathway in diabetic cardiomyopathy	20
Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries	20
Rapid neutrophil mobilization by VCAM-1+ endothelial cell-derived extracellular vesicles	20
Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 recept	20
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload	20
Central and peripheral sympathetic activation in heart failure	20
Heritable arrhythmias associated with abnormal function of cardiac potassium channels	20
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development	20
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms	20
Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells	20
Non-invasive transcutaneous vagal nerve stimulation improves myocardial performance in doxorubicin-induced cardiotoxicity	20
Recent advances in the role of the adenosinergic system in coronary artery disease	20
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective	20
Extracellular histones are a target in myocardial ischaemia–reperfusion injury	20
Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus	20
No sex-related differences in infarct size, no-reflow, and protection by ischaemic pre-conditioning in Göttingen minipigs	19
Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction	19
The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation	19
Novel insights into the electrophysiology of murine cardiac macrophages: relevance of voltage-gated potassium channels	19
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study	19
Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage	19
Role of interleukin-23/interleukin-17 axis in T-cell-mediated actions in hypertension	19
Deletion of fibroblast activation protein provides atheroprotection	19
Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129	19
SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX	19
Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion	19
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside	19
Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on C	19
Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity	18
Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia	18
Haploinsufficiency ofTmem43in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy	18
Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome	18
Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice	18
Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension	18
Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension	18
Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation	18
Targeting DNA damage response in cardiovascular diseases: from pathophysiology to therapeutic implications	18
Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes	18
Genome-wide association studies of cardiac electrical phenotypes	18
Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility	18
Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials	18
Neuroimmune interactions in cardiovascular diseases	18
Cell senescence: basic mechanisms and the need for computational networks in vascular ageing	18
Heterogeneous subpopulations of adventitial progenitor cells regulate vascular homeostasis and pathological vascular remodelling	18
SPEG: a key regulator of cardiac calcium homeostasis	18
Dilated cardiomyopathy-linked heat shock protein family D member 1 mutations cause up-regulation of reactive oxygen species and autophagy through mitochondrial dysfunction	17
Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events	17
Anxa1 in smooth muscle cells protects against acute aortic dissection	17
Acute coronary syndrome is associated with a substantial change in the platelet lipidome	17
Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature	17
Loss of myeloid cell-specific SIRPα, but not CD47, attenuates inflammation and suppresses atherosclerosis	17
Temporal relationship between systemic endothelial dysfunction and alterations in erythrocyte function in a murine model of chronic heart failure	17
Trimethylamine N-oxide induces osteogenic responses in human aortic valve interstitial cells in vitro and aggravates aortic valve lesions in mice	17
Cardiovascular comorbidities, inflammation, and cerebral small vessel disease	17